TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 55nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
US Patent
Affinity DataIC50: 55nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
